123 related articles for article (PubMed ID: 12613509)
21. Arsenic trioxide and the growth of human T-cell leukemia virus type I infected T-cell lines.
Ishitsuka K; Hanada S; Uozumi K; Utsunomiya A; Arima T
Leuk Lymphoma; 2000 May; 37(5-6):649-55. PubMed ID: 11042529
[TBL] [Abstract][Full Text] [Related]
22. In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.
Wagner M; Schmelz K; Wuchter C; Ludwig WD; Dörken B; Tamm I
Int J Cancer; 2006 Sep; 119(6):1291-7. PubMed ID: 16619249
[TBL] [Abstract][Full Text] [Related]
23. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
Ikeguchi M; Kaibara N
Br J Cancer; 2002 Oct; 87(8):883-7. PubMed ID: 12373603
[TBL] [Abstract][Full Text] [Related]
24. Nuclear survivin as a biomarker for non-small-cell lung cancer.
Lu B; Gonzalez A; Massion PP; Shyr Y; Shaktour B; Carbone DP; Hallahan DE
Br J Cancer; 2004 Aug; 91(3):537-40. PubMed ID: 15266313
[TBL] [Abstract][Full Text] [Related]
25. [Expression of survivin and its location in bone marrow cells of childhood acute leukemia: relationship to therapeutic efficacy].
Hou Y; Hu Q; Liu AG; Zhang LQ; Liu SY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):101-4. PubMed ID: 16613699
[TBL] [Abstract][Full Text] [Related]
26. Survivin and aven: two distinct antiapoptotic signals in acute leukemias.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Sahin B; Burgut R
Ann Oncol; 2003 Jul; 14(7):1045-50. PubMed ID: 12853345
[TBL] [Abstract][Full Text] [Related]
27. Expression of survivin gene in apoptosis induced by dexamethasone in CEM cells.
He L; Liu YP; Hou KZ; Li D; Zhu ZT; Zhang JD
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):173-6. PubMed ID: 16787583
[TBL] [Abstract][Full Text] [Related]
28. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas.
Mahotka C; Krieg T; Krieg A; Wenzel M; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
Int J Cancer; 2002 Jul; 100(1):30-6. PubMed ID: 12115583
[TBL] [Abstract][Full Text] [Related]
29. Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine.
Takeuchi H; Morton DL; Elashoff D; Hoon DS
Int J Cancer; 2005 Dec; 117(6):1032-8. PubMed ID: 15986442
[TBL] [Abstract][Full Text] [Related]
30. [Expression of survivin in ovarian epithelial carcinoma and its correlation with expression of Fas and FasL].
Ma XY; He FX; Wu SF; Lu YP; Ma D
Ai Zheng; 2004 Feb; 23(2):173-6. PubMed ID: 14960238
[TBL] [Abstract][Full Text] [Related]
31. [Advance of research on survivin in hematological malignancies--review].
Xiong HX; Chen BA; Ding JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):866-9. PubMed ID: 15631681
[TBL] [Abstract][Full Text] [Related]
32. Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer.
Miyachi K; Sasaki K; Onodera S; Taguchi T; Nagamachi M; Kaneko H; Sunagawa M
Gastric Cancer; 2003; 6(4):217-24. PubMed ID: 14716515
[TBL] [Abstract][Full Text] [Related]
33. [Survivin: anti-apoptosis protein and a prognostic marker for tumor progression and recurrence].
Sela B
Harefuah; 2002 Jan; 141(1):103-7, 123. PubMed ID: 11851094
[TBL] [Abstract][Full Text] [Related]
34. Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation.
Nagasaki M; Zhang J; Morikawa S; Harada T; Nabika T; Tanaka Y
Pathol Int; 2005 May; 55(5):264-72. PubMed ID: 15871724
[TBL] [Abstract][Full Text] [Related]
35. Correlation between survivin mRNA expression and homoharringtonine induced apoptosis of malignant hematopoietic cells.
Cai Z; Bao HY; Lin MF
Chin Med J (Engl); 2005 Apr; 118(7):548-54. PubMed ID: 15820085
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax.
Kawakami H; Tomita M; Matsuda T; Ohta T; Tanaka Y; Fujii M; Hatano M; Tokuhisa T; Mori N
Int J Cancer; 2005 Jul; 115(6):967-74. PubMed ID: 15729715
[TBL] [Abstract][Full Text] [Related]
37. A survivin-responsive, conditionally replicating adenovirus induces potent cytocidal effects in adult T-cell leukemia/lymphoma.
Suzuki S; Kofune H; Uozumi K; Yoshimitsu M; Arima N; Ishitsuka K; Ueno SI; Kosai KI
BMC Cancer; 2019 May; 19(1):516. PubMed ID: 31142289
[TBL] [Abstract][Full Text] [Related]
38. Expression of functional lung resistance--related protein predicts poor outcome in adult T-cell leukemia.
Ohno N; Tani A; Uozumi K; Hanada S; Furukawa T; Akiba S; Sumizawa T; Utsunomiya A; Arima T; Akiyama S
Blood; 2001 Aug; 98(4):1160-5. PubMed ID: 11493465
[TBL] [Abstract][Full Text] [Related]
39. WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells.
Moles R; Bai XT; Chaib-Mezrag H; Nicot C
J Hematol Oncol; 2016 Nov; 9(1):121. PubMed ID: 27829440
[TBL] [Abstract][Full Text] [Related]
40. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
